Tai-Chi-Chuan on Differentiation and Maturation of Dendritic Cells
NCT00322959 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2008-09-22
Summary
Tai-Chi-Chuan (TCC), a branch of traditional Chinese martial arts, has been widely practiced since the 17th century. Recent studies have shown that TCC can improve cardiorespiratory function, muscle strength, humoral and cellular immunity, metabolic response and mental control.
Cultured monocytes from blood or bone marrow can be triggered to differentiate to myeloid dendritic cells (DC). DCs are specialized leukocytes for presenting antigens to quiescent, naive, and memory T cells, and they play pivotal roles in the induction of cell-mediated as well as humoral immune responses in vivo. Mature DCs have a capacity for initiating immunity or tolerance, which depends on their activation state.
In this study we will investigate the effect of TCC on DC differentiation in the peripheral blood obtained from the healthy donors who take part with and without TCC exercise. The distribution of various DC sub-populations (myeloid DC and plasmacytoid cell) will be analyzed by detecting surface marker expression.
Conditions
- Immunity
Sponsors & Collaborators
-
Mackay Memorial Hospital
lead OTHER
Principal Investigators
-
Yu-Jen Chen, MD, PhD · Mackay Memorial Hospital
Eligibility
- Min Age
- 25 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-08-31
- Primary Completion
- 2006-11-30
- Completion
- 2006-11-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals
NCT00320164 ·Status: COMPLETED
-
Functional Characterization of CD8+ T Cells After Supramaximal Exercise
NCT06484101 ·Status: COMPLETED ·Phase: NA
-
Development of a Cell Culture Process for the Production of Human T-lymphocyte Precursors
NCT05118113 ·Status: UNKNOWN ·Phase: NA
-
Identification and Characterization of SARS-CoV-2 Specific CD8 T Cells in Humans
NCT04565067 ·Status: ACTIVE_NOT_RECRUITING
-
Study of DC-CTL Combined With CIK for Advanced Solid Tumor
NCT03047525 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus
NCT00001985 ·Status: COMPLETED
-
Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells
NCT00327496 ·Status: UNKNOWN ·Phase: NA
-
Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor
NCT04214717 ·Status: UNKNOWN ·Phase: NA
-
PBMC Collection for Production of UCAR T Cells
NCT04963959 ·Status: UNKNOWN ·Phase: NA
-
microRNA Profile in Umbilical Cord Blood NK Cells
NCT00751569 ·Status: UNKNOWN
-
Evaluation of Immune Signaling Networks in Healthy Human Volunteers
NCT01882582 ·Status: COMPLETED
-
Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer
NCT03113019 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
NCT00571389 ·Status: RECRUITING
-
Sequencing T-cells in Type I Diabetes Mellitus
NCT02040337 ·Status: COMPLETED
-
Impaired Immunity in Patients With Cancer: Influence of Cancer Stage, Chemotherapy, and Cytomegalovirus Infection
NCT00521287 ·Status: UNKNOWN ·Phase: PHASE2
-
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
NCT00576537 ·Status: COMPLETED ·Phase: PHASE2
-
Dendritic Killer Cell-based Immunotherapy for Solid Tumors
NCT02882659 ·Status: UNKNOWN ·Phase: PHASE1
-
Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma
NCT01235845 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Biological Therapy in Treating Patients With Advanced Cancer
NCT00005956 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma
NCT00430053 ·Status: COMPLETED
-
Safety Study of Adoptive Transfer of Autologous IKDC-like Cells
NCT02661685 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of DC-CIK to Treat Hepatocellular Carcinoma
NCT01821482 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Systemically Administered Hydrocortisone on the Immune System in Healthy Volunteers
NCT01281995 ·Status: COMPLETED
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
DC/NK Cell Therapy
NCT07202611 ·Status: RECRUITING ·Phase: PHASE2